Global Corporate Venturing: Healthcare Innovation.
-
Upload
reynold-gilmore -
Category
Documents
-
view
218 -
download
2
Transcript of Global Corporate Venturing: Healthcare Innovation.
Global Corporate Venturing: Healthcare Innovation
Penetration of CVC by Industry
Source: BCG, October 2012, analysing Global Corporate Venturing’s data
New health funds and commitments
• GSK’s $50m bioelectronic fund and LP commitment to Kurma Biofund II
• Stanford-StartX• Cipla incubator• BI joins Rockspring• Amgen and Novartis partner with Atlas• Bayer and Roche to QB3• MS Ventures doubles to €100m• Quintiles’ NovaQuestSource: Sample selected www.GlobalCorporat Venturing.com in 2013
Q2 Fundraising and Trends
ParentCorporate Venturing Unit/Fund Size Parent's Region Sector
TataTata Opportunities Fund $600m Asia Industrial
Unilever Unllever Ventures $450m Europe Consumer
SAP Hana Fund $250m* Europe IT
ShellShell Technology Ventures $100ms* Europe Energy
Merck MS Ventures €100m* Europe Health
Grupo RBS e.Bricks Digital $100m RoW IT
Infosys Fund $100m Asia IT
Giant Interactive Group Pleb Dream Fund RMB1bn ($161m) Asia Media
Intel Perceptual fund $100m US IT
Quintiles NovaQuest $80m US Health
Source: Global Corporate Venturing* expansion of existing fund
Healthcare CVC’s narcissism
Source: BCG, October 2012, analysing Global Corporate Venturing’s 1,300 deals
Source: Global
Corporate Venturing
2011-13 Deal
Activity
Source: Global Corporate Venturing
Q2 2013 activity
Source: Global Corporate Venturing
Q2 Deal Activity
• 246 investments worth $5bn• 40 exits – IPOs picking up by number• M&A from portfolio companies up by a third• Series A leads by number of deals• IT most active, healthcare rebounds,• Asia and Europe increasing but US leads
“A global, multimedia publishing group dedicated to serving the intermediaries directing funding to entrepreneurs in the innovation
economy.”
Contact: James Mawson, founder and editor-in-chief [email protected]+1 650 906 1356 (US main) or +44 (0) 7971655590 (UK)